MedPath

Endoscopic balloon dilation followed by steroid injection for anastomotic strictures after hepaticojejunostomy

Phase 1
Recruiting
Conditions
Hepaticojejunostomy stricture
Registration Number
JPRN-jRCTs041190091
Lead Sponsor
Sato Junya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
35
Inclusion Criteria

1) Patient with suspected hepaticjejunostomy stricture
2) Patient with >= 20 yo
3) Patient with performance status 1-2
4) Patient without organ dysfunction

Exclusion Criteria

1) Patient with malignant hepaticojejunostomy stricture
2) Patient who cannot stop anti-platelet agent
3) Patient who take steroids or immunosuppressive agents regulary
4) Allergy for triamcinolone
5) Pregnant woman
6) Patient with psychiatric disorder or dementia
7) Patient with severe diabetes mellitus, hypertension, penumonia, digestive tract bleeding, heart failure, angina, or cardial infaction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Phase 1: Adverse events rate within 1 week after treatment<br>Phase 2: Hepaticojejunostomy stricture recurrence rate after 1 year after treatment
Secondary Outcome Measures
NameTimeMethod
Phase2<br>Adverse events rate within 1 week after treatment<br>Hepaticojejunostomy stricture recurrence rate after 2 or 3 year after treatment<br>Late adverse events
© Copyright 2025. All Rights Reserved by MedPath